Skip to Main Content

Paper Details

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
63
2022
ALL, Acute Lymphoblastic Leukemia, B, B-cell, B-cell aplasia, CAR, CAR-T cell, CD19, Children, acute lymphoblastic leukemia, chimeric antigen receptor, chimeric antigen receptor (CAR) T cells, patients
Author NameAffiliation
Stephan A GruppPerelman School of Medicine, University of Pennsylvania
Stephan A GruppCenter for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia
  • 1 - 2

Datasets

Release 1.2